Arch Biopartners Inc. — Form D
Arch Biopartners Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-18. The offering totals $156K, of which $156K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-08-18
- Form: D
- Accession: 0001600660-14-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $156K
- Amount sold: $156K
- Investors: 4
- Date of first sale: 2014-08-05
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-223116
Issuer
- Name: Arch Biopartners Inc.
- CIK: 0001600660
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 174 SPADINA AVENUE, TORONTO, A6, M5T 2C2
- Phone: 6474287031
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Andrew Bishop | Director | Halifax, A5 |
| Andrew Bishop | Executive Officer | Halifax, A5 |
| Adrian Haigh | Director | RESEARCH TRIANGLE PARK, NC |
| Richard Muruve | Director | Toronto, A6 |
| Richard Muruve | Executive Officer | Toronto, A6 |
| Daniel Muruve | Executive Officer | Toronto, A6 |
| Richard Rossman | Director | Toronto, A6 |
| Claude Allary | Director | Paris, I0 |
| Conor Gunne | Director | Toronto, A6 |
| Jerome McElroy | Director | Toronto, A6 |
Other filings by this issuer (3)
More